[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=473a91df2c96ef98d24c2a3bde5494aa8fdc1265d7b8130bd7f67cb8b64875a2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758818460,
      "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "id": 136925588,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=473a91df2c96ef98d24c2a3bde5494aa8fdc1265d7b8130bd7f67cb8b64875a2"
    }
  },
  {
    "ts": null,
    "headline": "BMS expands DTC offering with Sotyktu addition",
    "summary": "Patients will now be able to access Eliquis and Sotyktu for significantly cheaper than their current list prices.",
    "url": "https://finnhub.io/api/news?id=80c38b686b7275b5f26acbbba9ef9077748c339f130a041644446f8a25c4602b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758816674,
      "headline": "BMS expands DTC offering with Sotyktu addition",
      "id": 136884303,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Patients will now be able to access Eliquis and Sotyktu for significantly cheaper than their current list prices.",
      "url": "https://finnhub.io/api/news?id=80c38b686b7275b5f26acbbba9ef9077748c339f130a041644446f8a25c4602b"
    }
  },
  {
    "ts": null,
    "headline": "PGIM Jennison Health Sciences Fund Sold its Position in Bristol-Myers Squibb Co. (BMY) in Q2",
    "summary": "PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities in the second quarter of 2025 experienced significant volatility, as the steep sell-off that initiated at the beginning of the quarter ultimately led to a strong recovery. The S&P […]",
    "url": "https://finnhub.io/api/news?id=79d01abbc5cd3962f80d4aec0758a7f9112e88e8999d00524a4289935a77ba88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758809157,
      "headline": "PGIM Jennison Health Sciences Fund Sold its Position in Bristol-Myers Squibb Co. (BMY) in Q2",
      "id": 136883278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities in the second quarter of 2025 experienced significant volatility, as the steep sell-off that initiated at the beginning of the quarter ultimately led to a strong recovery. The S&P […]",
      "url": "https://finnhub.io/api/news?id=79d01abbc5cd3962f80d4aec0758a7f9112e88e8999d00524a4289935a77ba88"
    }
  },
  {
    "ts": null,
    "headline": "Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors",
    "summary": "See why Teva Pharmaceutical Industries Limited is shifting the CNS market with Austedo sales growth, new clinical data, and falling debt. Click for my TEVA update.",
    "url": "https://finnhub.io/api/news?id=5654cabe84142939f60002314d296e69ec9908de40922b5433a5fc21b4e997df",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758800565,
      "headline": "Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors",
      "id": 136882693,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196049070/image_2196049070.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "See why Teva Pharmaceutical Industries Limited is shifting the CNS market with Austedo sales growth, new clinical data, and falling debt. Click for my TEVA update.",
      "url": "https://finnhub.io/api/news?id=5654cabe84142939f60002314d296e69ec9908de40922b5433a5fc21b4e997df"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)",
    "summary": "PRINCETON, N.J., September 25, 2025--Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu®...",
    "url": "https://finnhub.io/api/news?id=232104e1e14d07201c07a995b38afbde0771e1a8a4e7bcece2417f256a8cb75b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758797940,
      "headline": "Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)",
      "id": 136883279,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., September 25, 2025--Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu®...",
      "url": "https://finnhub.io/api/news?id=232104e1e14d07201c07a995b38afbde0771e1a8a4e7bcece2417f256a8cb75b"
    }
  },
  {
    "ts": null,
    "headline": "Keros Therapeutics: A Potential Dart Throw",
    "summary": "Keros Therapeutics: A Potential Dart Throw",
    "url": "https://finnhub.io/api/news?id=05f410b7ecb3b6b6b28725ebf01030ba919cab82defec639b4f33328826534eb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758795349,
      "headline": "Keros Therapeutics: A Potential Dart Throw",
      "id": 136882436,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=05f410b7ecb3b6b6b28725ebf01030ba919cab82defec639b4f33328826534eb"
    }
  }
]